<DOC>
	<DOCNO>NCT00362362</DOCNO>
	<brief_summary>This study collect blood sample patient primary lateral sclerosis ( PLS ) amyotrophic lateral sclerosis ( ALS ) use research genetic cause motor neuron diseases neurological disorder . Patients 18 year age old PLS ALS may eligible study . Candidates screen medical history , physical examination diagnostic test . Participants provide blood sample . The sample , along mask ( anonymous ) medical family history information send NINDS Respository Coriell Cell Repositories Camden , NJ . This facility collect , store distribute medical research information cell culture DNA sample researcher hospital , university commercial organization . The blood sample identification number unrelated identify information patient track back patient .</brief_summary>
	<brief_title>Collection Blood Samples DNA Motor Neuron Disease</brief_title>
	<detailed_description>OBJECTIVE : The cause sporadic motor neuron disease , primary lateral sclerosis ( PLS ) amyotrophic lateral sclerosis ( ALS ) unknown . Genes identify form familial motor neuron disease . We n't know whether gene also play role sporadic motor neuron disease , example risk-factor gene interaction multiple gene complex genetic disorder . Identification genetic contribution sporadic motor neuron diseases require analysis DNA patient . The goal protocol collect blood sample patient motor neuron disease creation cell line bank repository create NINDS initiative . The cell line use DNA extraction . The repository provide anonymized sample patient DNA cell line investigator seek define genetic cause , contribution , susceptibility neurological disorder . DNA cell line create blood sample strip patient identifier store indefinitely . A limited amount clinical data , term clinical data element , available coded sample . The sample available research . The result test communicated patient . STUDY POPULATION : All patient enrol primary protocol study motor neuron diseases NIH . This protocol serve secondary protocol sample collection report clinical data element . Patients Primary lateral sclerosis must meet diagnostic criterion PLS propose Pringle patient ALS must fulfill revise El Escorial criterion probable definite ALS . DESIGN : Determination diagnosis eligibility carry part primary protocol . Patients inform DNA sample repository purpose . After informed consent obtain , 2 tube blood drawn assign unique identifier code . The coded sample , clinical data element form send repository , extract DNA prepare cell line . The identity subject store . An aliquot sample forward associate investigator look disease association genetic marker . OUTCOME MEASURES : There specific outcome measure protocol . The sample make accessible wide variety researcher seek determine cause motor neuron diseases neurological disorder repository 's contract NINDS .</detailed_description>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<criteria>PRIMARY LATERAL SCLEROSIS INCLUSION CRITERIA : Patients PLS , age 18 old , must meet diagnostic criterion propose Pringle ( 1992 ) , incorporate Santa Clara ( 2004 ) consensus pure PLS . Clinical : Insidious onset adulthood , progressive course No family history Disease duration great 3 year without low motor neuron clinical sign Clinical sign restrict corticospinal/corticobulbar tract dysfunction Imaging : Brain MRI normal ( except cortical atrophy ) Normal cervical spine Negative chest Xray , negative mammogram woman EMG 3 year , within last 3 year , show active denervation . Normal serological study serum chemistry , Vitamin B12 , Vitamin E level , longchain fatty acid . Negative serology syphilis , Lyme disease , HTLV 1 2 . AMYOTROPHIC LATERAL SCLEROSIS INCLUSION CRITERIA : Patients ALS , age 18 old , must fulfill revise El Escorial criterion probable definite ALS . Probable ALS : Upper Lower motor neuron sign present two region , UMN sign must rostral LMN sign . Definite ALS : Upper Lower motor neuron sign present three region . EXCLUSION CRITERIA :</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 9, 2013</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Primary Lateral Sclerosis</keyword>
	<keyword>Genetics</keyword>
	<keyword>Blood Sample</keyword>
	<keyword>PLS</keyword>
	<keyword>ALS</keyword>
</DOC>